Tanimoto Weki M, Sigler Morales L, Treviño García-Manzo N, Gallardo-Angulo V E, Pérez-Roa J
Rev Gastroenterol Mex. 1989 Jul-Sep;54(3):163-6.
In Mexico, like in other countries, there is an special interest for amebiasis because it represents a Public health problem; there are about 5 million people that in some time of their lives had tissue invasion by this parasite. 1-2% of mexicanas have intestinal amebiasis and probably there are 850,000 to 1,700,000 carriers of entamoeba cysts. 6% of the general population have circulating antiameba antibodies. In 1988 we studied the amebic hepatic abscess seen in the hospitals of the Instituto Mexicano del Seguro Social in the Valley of Mexico. During that year there were 396 patients with such illness (0.19% of hospital admissions) with a 1.01% mortality. Comparing this data with reports of 1969 there was a reduction in the number of patients and deaths. Also amebiasis has decreased in autopsy studies. However, we have not found recent variations in the clinical behavior of amebiasis. Advances in diagnostic methods and more liberal use of metronidazole have reduced the number of severely ill patients.
在墨西哥,和其他国家一样,人们对阿米巴病有着特殊的关注,因为它是一个公共卫生问题;大约有500万人在生命中的某个时期曾遭受这种寄生虫的组织侵袭。1%至2%的墨西哥女性患有肠道阿米巴病,可能有85万至170万溶组织内阿米巴囊肿携带者。普通人群中有6%的人循环抗阿米巴抗体呈阳性。1988年,我们研究了墨西哥社会保障局在墨西哥谷医院所见到的阿米巴肝脓肿情况。在那一年,有396例此类疾病患者(占住院人数的0.19%),死亡率为1.01%。将这些数据与1969年的报告相比较,患者数量和死亡人数都有所减少。在尸检研究中,阿米巴病也有所减少。然而,我们并未发现阿米巴病临床症状近期有变化。诊断方法的进步以及甲硝唑的更广泛使用减少了重症患者的数量。